Abstract:Transient receptor potential melastatin 2 (TRPM2), a non-selective cation channel, is involved in many physiological and pathological processes, including temperature sensing, synaptic plasticity regulation, and neurodegenerative diseases. However, the gating mechanism of TRPM2 channel is complex, which hinders its functional research. With the discovery of the Ca2+ binding site in the S2-S3 domain of TRPM2 channel, more and more attention has been drawn to the role of the transmembrane segments in channel gating. In this study, we focused on the D820-F867 segment around the S2 domain, and identified the key residues on it. Functional assays of the deletion mutants displayed that the deletions of D820-W835 and L836-P851 destroyed channel function totally, indicating the importance of these two segments. Sequence alignments on them found three polar and charged residues with high conservation (D820, E829, and R845). D820A, E829A, and R845A which removed the charge and the side chain of the residues were tested by 500 mu M adenosine diphosphate-ribose (ADPR) or 50 mM Ca2+. E829A and R845A affected the characteristic of channel currents, while D820A behaved similarly to WT, indicating the participations of E829 and R845 in channel gating. The charge reversing mutants, E829K and R845D were then constructed and the electrophysiological tests showed that E829A and E829K made the channel lose function. Interestingly, R845A and R845D exhibited an inactivation process when using 500 mu M ADPR, but activated normally by 50 mM Ca2+. Our data suggested that the negative charge at E829 took a vital part in channel activation, and R845 increased the stability of the Ca2+ combination in S2-S3 domain, thus guaranteeing the opening of TRPM2 channel. In summary, our identification of the key residues E829 and R845 in the transmembrane segments of TRPM2. By exploring the gating process of TRPM2 channel, our work helps us better understand the mechanism of TRPM2 as a potential biomarker in neurodegenerative diseases, and provides a new approach for the prediction, diagnosis, and prognosis of neurodegenerative diseases.

The role of 14-3-3 dimerization in its modulation of the CaV2.2 channel.

The Role of 14-3-3 Dimerization in Its Modulation of the CaV2.2 Channel

Modulation of Inactivation Properties of CaV2.2 Channels by 14-3-3 Proteins

Effects of Calcium-Binding Sites in the S2–S3 Loop on Human and Nematostella Vectensis TRPM2 Channel Gating Processes

Structural mechanism of voltage-gated sodium channel slow inactivation.

The Tetramerization Domain Potentiates Kv4 Channel Function by Suppressing Closed-State Inactivation.

Molecular Regions Determining The Voltage-dependence of Inactivation for T-type Calcium Channel Ca(v)3.1

Structural Insights into KChIP4a Modulation of Kv4.3 Inactivation

A-Type Kv4 Channel Closed-State Inactivation is Modulated by the Tetramerization Domain Interacting with Auxilary KChIP4a

Role of the CaV1.2 distal carboxy terminus in the regulation of L-type current

Molecular insights into the gating mechanisms of voltage-gated calcium channel CaV2.3

Molecular Mechanism for Divergent Regulation of Cav1.2 Ca2+ Channels by Calmodulin and Ca2+-binding Protein-1

Closed-state inactivation and pore-blocker modulation mechanisms of human CaV2.2

The identification of the key residues E829 and R845 involved in transient receptor potential melastatin 2 channel gating

14-3-3τ Promotes Surface Expression of Cav2.2 (α1B) Ca2+ Channels

Structural bases of inhibitory mechanism of CaV1.2 channel inhibitors

Regulation and drug modulation of a voltage-gated sodium channel: Pivotal role of the S4–S5 linker in activation and slow inactivation

Molecular Basis for Ligand Modulation of a Mammalian Voltage-Gated Ca2+ Channel

Molecular Determinants of Ca2+/Calmodulin-Dependent Regulation of Ca(V)2.1 Channels

Structures of the R-type Human Cav2.3 Channel Reveal Conformational Crosstalk of the Intracellular Segments

Carboxyl Terminus As a Key Regulator of Gating and Signaling of L-Type Calcium Channels